Market Closed -
OTC Markets
03:30:12 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.05
USD
|
-31.13%
|
|
-58.33%
|
-77.16%
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,028
|
735.6
|
925
|
1,082
|
497.5
|
196.2
|
Enterprise Value (EV)
1 |
4,972
|
4,079
|
7,013
|
7,354
|
6,384
|
5,851
|
P/E ratio
|
2.12
x
|
-1.72
x
|
-2.02
x
|
-11.5
x
|
-0.92
x
|
-0.26
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.09
x
|
0.03
x
|
0.04
x
|
0.05
x
|
0.02
x
|
0.01
x
|
EV / Revenue
|
0.23
x
|
0.19
x
|
0.32
x
|
0.31
x
|
0.26
x
|
0.24
x
|
EV / EBITDA
|
9.66
x
|
8.2
x
|
12.2
x
|
16
x
|
14.1
x
|
20.4
x
|
EV / FCF
|
4.39
x
|
-6.71
x
|
15.7
x
|
-108
x
|
17.6
x
|
124
x
|
FCF Yield
|
22.8%
|
-14.9%
|
6.38%
|
-0.92%
|
5.7%
|
0.81%
|
Price to Book
|
1.26
x
|
0.63
x
|
1.36
x
|
1.72
x
|
5.03
x
|
-0.31
x
|
Nbr of stocks (in thousands)
|
53,091
|
53,385
|
53,778
|
55,224
|
54,199
|
54,799
|
Reference price
2 |
38.20
|
13.78
|
17.20
|
19.60
|
9.180
|
3.580
|
Announcement Date
|
4/26/18
|
4/25/19
|
4/27/20
|
4/27/21
|
4/25/22
|
5/1/23
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
21,529
|
21,640
|
21,928
|
24,043
|
24,568
|
24,092
|
EBITDA
1 |
514.9
|
497.7
|
573.3
|
458.8
|
453.6
|
287.1
|
EBIT
1 |
128.8
|
139.8
|
245.1
|
131.7
|
158
|
10.48
|
Operating Margin
|
0.6%
|
0.65%
|
1.12%
|
0.55%
|
0.64%
|
0.04%
|
Earnings before Tax (EBT)
1 |
-43.54
|
-589.5
|
-81.61
|
-120.2
|
-542.3
|
-756.4
|
Net income
1 |
943.5
|
-422.2
|
-452.2
|
-90.91
|
-538.5
|
-749.9
|
Net margin
|
4.38%
|
-1.95%
|
-2.06%
|
-0.38%
|
-2.19%
|
-3.11%
|
EPS
2 |
17.98
|
-7.989
|
-8.500
|
-1.699
|
-9.962
|
-13.71
|
Free Cash Flow
1 |
1,132
|
-608.1
|
447.8
|
-67.86
|
363.7
|
47.18
|
FCF margin
|
5.26%
|
-2.81%
|
2.04%
|
-0.28%
|
1.48%
|
0.2%
|
FCF Conversion (EBITDA)
|
219.79%
|
-
|
78.1%
|
-
|
80.18%
|
16.43%
|
FCF Conversion (Net income)
|
119.95%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/18
|
4/25/19
|
4/27/20
|
4/27/21
|
4/25/22
|
5/1/23
|
Fiscal Period: March |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
6,161
|
6,113
|
6,229
|
6,065
|
6,015
|
5,901
|
6,083
|
6,093
|
5,653
|
EBITDA
1 |
138.9
|
106.2
|
154.8
|
106.1
|
100.1
|
78.55
|
121.9
|
128.6
|
91.72
|
EBIT
1 |
63.02
|
32.3
|
81.82
|
33.08
|
30.06
|
9.985
|
52.42
|
60.14
|
25.82
|
Operating Margin
|
1.02%
|
0.53%
|
1.31%
|
0.55%
|
0.5%
|
0.17%
|
0.86%
|
0.99%
|
0.46%
|
Earnings before Tax (EBT)
1 |
-12.28
|
-96.99
|
-37.23
|
-395.8
|
-106.7
|
-319.3
|
-67.65
|
-262.7
|
-305.2
|
Net income
|
-13.06
|
-100.3
|
-36.06
|
-389.1
|
-110.2
|
-
|
-67.14
|
-241.3
|
-
|
Net margin
|
-0.21%
|
-1.64%
|
-0.58%
|
-6.41%
|
-1.83%
|
-
|
-1.1%
|
-3.96%
|
-
|
EPS
2 |
-0.2400
|
-1.860
|
-0.6700
|
-7.190
|
-2.030
|
-6.070
|
-1.230
|
-4.390
|
-5.560
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/24/21
|
9/23/21
|
12/21/21
|
4/14/22
|
6/23/22
|
9/29/22
|
12/21/22
|
4/20/23
|
6/29/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,944
|
3,343
|
6,088
|
6,271
|
5,886
|
5,655
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.718
x
|
6.718
x
|
10.62
x
|
13.67
x
|
12.98
x
|
19.7
x
|
Free Cash Flow
1 |
1,132
|
-608
|
448
|
-67.9
|
364
|
47.2
|
ROE (net income / shareholders' equity)
|
-31.6%
|
-47.8%
|
-50.4%
|
-15.5%
|
-151%
|
276%
|
ROA (Net income/ Total Assets)
|
0.78%
|
1.05%
|
1.8%
|
0.88%
|
1.11%
|
0.08%
|
Assets
1 |
120,587
|
-40,062
|
-25,159
|
-10,377
|
-48,722
|
-920,167
|
Book Value Per Share
2 |
30.30
|
22.00
|
12.60
|
11.40
|
1.830
|
-11.60
|
Cash Flow per Share
2 |
8.480
|
2.670
|
4.080
|
2.990
|
0.7300
|
2.850
|
Capex
1 |
186
|
197
|
172
|
195
|
194
|
215
|
Capex / Sales
|
0.86%
|
0.91%
|
0.78%
|
0.81%
|
0.79%
|
0.89%
|
Announcement Date
|
4/26/18
|
4/25/19
|
4/27/20
|
4/27/21
|
4/25/22
|
5/1/23
|
|
1st Jan change
|
Capi.
|
---|
| -77.16% | 2.75M | | -12.86% | 8.57B | | +32.95% | 1.32B | | +6.76% | 419M | | +5.93% | 282M | | +10.56% | 224M | | -8.26% | 85.07M | | +20.94% | 59.57M |
Retail - Drugs without Grocery
|